Hearings Held on Compounding Pharmacy

Published Online: Thursday, December 13, 2012
Follow Pharmacy_Times:
In 2 days of hearings held in November 2012, congressional representatives and senators began to grapple with how to respond to the ongoing fungal meningitis outbreak linked to tainted steroids produced by a Massachusetts compounding pharmacy. In general, senators from both parties and Democratic representatives seemed inclined to give the FDA greater authority over compounding pharmacies, whereas some Republican representatives were hesitant. Lawmakers from both parties criticized the FDA for not doing more to prevent the outbreak.

At the hearings, FDA Commissioner Margaret Hamburg, MD, called her agency’s authority over compounding pharmacies, which are generally overseen by state pharmacy boards, “limited, unclear, and contested.” She proposed creating a distinction between “traditional” compounding pharmacies, which produce medications in response to individual prescriptions, and “nontraditional” compounding pharmacies, which would be required to follow rules that apply to drug manufacturers.

Several Republicans on the House Energy and Commerce Oversight and Investigations Subcomittee, however, suggested that the FDA already had the authority necessary to have prevented the outbreak and failed to properly exercise it. Hamburg countered that none of the actions the agency could have taken under existing law would have prevented the outbreak.

Related Articles
On the heels of a 4-day mass vaccination clinic on campus to prevent the spread of meningococcemia, a fifth student at the University of Oregon was diagnosed with the bacterial precursor to meningitis.
Compounding pharmacies across the nation face tighter regulations following the 2012 fungal meningitis outbreak from tainted drugs distributed by the New England Compounding Center.
Lisa Faast, PharmD, pharmacy business specialist and member of Pharmacy Development Services, talks about how pharmacists' awareness of sterile compounding procedures has changed since the 2012 meningitis outbreak.
A bacterial precursor to meningitis has been blamed for the death of a University of Oregon (UO) student, and now a University of California, Davis, (UC Davis) student is recuperating in the hospital from the same type of infection.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$